Xiaohu Deng
Director Técnico/Científico/I+D en Vividion Therapeutics, Inc. .
Perfil
Xiaohu Deng is currently the Head-Technical Operations at Vividion Therapeutics, Inc. Prior to this, he worked as the Senior Director & Head-CMC at Kura Oncology, Inc. and as the Senior Vice President-Product Development at Viracta Therapeutics, Inc. Deng holds a doctorate degree from Emory University and undergraduate and graduate degrees from Fudan University.
Cargos activos de Xiaohu Deng
| Empresas | Cargo | Inicio |
|---|---|---|
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Xiaohu Deng.
| Empresas | Cargo | Fin |
|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Xiaohu Deng.
| Emory University | Doctorate Degree |
| Fudan University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Xiaohu Deng
